Quantcast

Latest AdvanDX Stories

2014-03-18 12:31:11

WOBURN, Mass., March 18, 2014 /PRNewswire/ -- AdvanDx today announced that it has submitted to the U.S. Food and Drug Administration for 510(k) clearance its new mecA XpressFISH(TM) test for the rapid detection of methicillin-resistant Staphylococcus aureus (MRSA) from S. aureus positive blood cultures. This assay will provide physicians with a new way to rapidly identify MRSA enabling them to implement appropriate treatment for patients with bloodstream infections....

2011-01-17 07:00:00

WOBURN, Mass. and VEDBAEK, Denmark, Jan. 17, 2011 /PRNewswire/ -- AdvanDx today announced that it has received FDA 510(k) clearance for its GNR Traffic Light(TM) PNA FISH(R) test. GNR Traffic Light PNA FISH is the first test capable of simultaneously identifying Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa directly from positive blood cultures containing Gram-negative rods in less than 90 minutes. The test is the latest addition to AdvanDx's easy-to-use,...

2010-08-12 01:00:00

WOBURN, Mass. and VEDBAEK, Denmark, Aug. 12 /PRNewswire/ -- AdvanDx today announced the launch of its CE-IVD marked GNR Traffic Light(TM) PNA FISH® test in Europe. GNR Traffic Light PNA FISH is the first-ever test capable of simultaneously identifying Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa directly from positive blood cultures in less than 90 minutes. The GNR Traffic Light is the latest addition to AdvanDx's easy-to-use, molecular-based PNA...

2010-07-29 07:00:00

WOBURN, Mass.and VEDBAEK, Denmark, July 29 /PRNewswire/ -- AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its Yeast Traffic Light® PNA FISH® test. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes. Clinical validation studies performed at hospitals in the United States demonstrated...

2010-05-24 08:00:00

WOBURN, Mass., May 24 /PRNewswire/ -- AdvanDx today announced that it will offer the BinaxNOW® PBP2a test from Inverness Medical Innovations, Inc. (Waltham, MA) to customers in the United States. The test provides rapid detection of the penicillin-binding protein 2a (PBP2a) present in Methicillin-Resistant Staphylococcus aureus (MRSA) directly from S. aureus positive blood cultures. In clinical studies, the test demonstrated 97.1% positive agreement and 100% negative...

2010-03-31 07:00:00

WOBURN, Mass. and VEDBAEK, Denmark, March 31 /PRNewswire/ -- AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its C. albicans PNA FISH® and C. albicans/C. glabrata PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes. Clinical validation studies performed at hospitals...

2009-12-22 07:00:00

WOBURN, Mass. and VEDBAEK, Denmark, Dec. 22 /PRNewswire/ -- AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its E. coli/P. aeruginosa PNA FISH® and EK/P. aeruginosa PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes. Clinical validation studies performed at hospitals...

2009-12-10 07:00:00

WOBURN, Mass., and VEDBAEK, Denmark, Dec. 10 /PRNewswire/ -- AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its S. aureus PNA FISH® and S. aureus/CNS PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes. Clinical validation studies performed at hospitals in the United...

2009-08-18 01:00:00

WOBURN, Mass. and VEDBAEK, Denmark, Aug. 18 /PRNewswire/ -- AdvanDx today announced it has closed another $8 million in financing from existing stockholders, SLS Venture and LD Pensions. The additional investment is part of a series C round of financing, the first part of which was closed in September 2007, and will be used to fund the expansion of AdvanDx's molecular diagnostics product offering as well as its international sales and marketing activities. In addition to the financing,...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.